Neil Fleshner
Technik-/Wissenschafts-/F&E-Leiter bei POINT Biopharma, Inc. (United States)
Aktive Positionen von Neil Fleshner
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
University of Toronto | Corporate Officer/Principal | - | - |
POINT Biopharma Corp.
POINT Biopharma Corp. Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma Corp. is a Canadian company that develops next-generation radiopharmaceuticals for the treatment of cancer. The company is based in Toronto, Canada. POINT Biopharma develops radioligands, which are microscopic, cancer-seeking missiles used to diagnose and treat cancers such as non-Hodgkin's lymphoma and neuroendocrine tumors (NETs). To learn more about the company, interested parties can register online at https\://hub.pointbiopharma.com/investor-day-june-2023. The company was founded by Joe McCann. Joe McCann has been the CEO since incorporation. | Direktor/Vorstandsmitglied | - | - |
Technik-/Wissenschafts-/F&E-Leiter | - | - | |
POINT Biopharma, Inc. (United States)
POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million. | Direktor/Vorstandsmitglied | 01.09.2019 | - |
Technik-/Wissenschafts-/F&E-Leiter | 01.01.2020 | - | |
Verity Pharmaceuticals, Inc.
Verity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Verity Pharmaceuticals, Inc. operates as a pharmaceutical company. It provides therapeutically relevant agents to the Canadian healthcare community. The company was founded in 2016 and is headquartered in Mississauga, ON. | Direktor/Vorstandsmitglied | 01.07.2016 | - |
Technik-/Wissenschafts-/F&E-Leiter | 01.07.2016 | - |
Karriereverlauf von Neil Fleshner
Ehemalige bekannte Positionen von Neil Fleshner
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
POIT BIOP | Direktor/Vorstandsmitglied | 30.06.2021 | 27.12.2023 |
Technik-/Wissenschafts-/F&E-Leiter | 30.06.2021 | 27.12.2023 | |
Gründer | 15.04.2020 | 27.12.2023 | |
Canadian Urologic Oncology Group
Canadian Urologic Oncology Group BiotechnologyHealth Technology Canadian Urologic Oncology Group operates as a clinical research investigator network. The company is headquartered in Vancouver, Canada. | Direktor/Vorstandsmitglied | - | - |
University Health Network
University Health Network Hospital/Nursing ManagementHealth Services University Health Network operates as a healthcare and medical research organization that provides patient care, education, and research services. Its programs include arthritis program, joint department of medical imaging, Krembil neuroscience center, laboratory medicine program, medical and community care, multi-organ transplant, Peter Munk cardiac center, Princess Margaret cancer, surgery and critical care program, and Toronto rehab. The company was founded in 1986 and is headquartered in Toronto, Canada. | Corporate Officer/Principal | - | - |
Princess Margaret Hospital | Corporate Officer/Principal | - | - |
Synergex Corp.
Synergex Corp. Air Freight/CouriersTransportation Synergex Corp. provides supply chain management services in Latin America. It specializes in logistics services, distribution, licensing, sales, localization, packaging and marketing of digital entertainment products. The company was founded in 1986 and is headquartered in Mississauga, Canada. | Direktor/Vorstandsmitglied | 05.12.2005 | - |
Independent Dir/Board Member | 05.12.2005 | - |
Ausbildung von Neil Fleshner
The Trustees of Columbia University in The City of New York | Graduate Degree |
University of Toronto | Doctorate Degree |
Statistik
International
Kanada | 8 |
Vereinigte Staaten | 4 |
Operativ
Director/Board Member | 6 |
Chief Tech/Sci/R&D Officer | 4 |
Corporate Officer/Principal | 3 |
Sektoral
Health Technology | 4 |
Consumer Services | 3 |
Commercial Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
POIT BIOP | Health Technology |
Private Unternehmen | 7 |
---|---|
University Health Network
University Health Network Hospital/Nursing ManagementHealth Services University Health Network operates as a healthcare and medical research organization that provides patient care, education, and research services. Its programs include arthritis program, joint department of medical imaging, Krembil neuroscience center, laboratory medicine program, medical and community care, multi-organ transplant, Peter Munk cardiac center, Princess Margaret cancer, surgery and critical care program, and Toronto rehab. The company was founded in 1986 and is headquartered in Toronto, Canada. | Health Services |
Synergex Corp.
Synergex Corp. Air Freight/CouriersTransportation Synergex Corp. provides supply chain management services in Latin America. It specializes in logistics services, distribution, licensing, sales, localization, packaging and marketing of digital entertainment products. The company was founded in 1986 and is headquartered in Mississauga, Canada. | Transportation |
Canadian Urologic Oncology Group
Canadian Urologic Oncology Group BiotechnologyHealth Technology Canadian Urologic Oncology Group operates as a clinical research investigator network. The company is headquartered in Vancouver, Canada. | Health Technology |
Princess Margaret Hospital | |
POINT Biopharma Corp.
POINT Biopharma Corp. Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma Corp. is a Canadian company that develops next-generation radiopharmaceuticals for the treatment of cancer. The company is based in Toronto, Canada. POINT Biopharma develops radioligands, which are microscopic, cancer-seeking missiles used to diagnose and treat cancers such as non-Hodgkin's lymphoma and neuroendocrine tumors (NETs). To learn more about the company, interested parties can register online at https\://hub.pointbiopharma.com/investor-day-june-2023. The company was founded by Joe McCann. Joe McCann has been the CEO since incorporation. | Commercial Services |
Verity Pharmaceuticals, Inc.
Verity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Verity Pharmaceuticals, Inc. operates as a pharmaceutical company. It provides therapeutically relevant agents to the Canadian healthcare community. The company was founded in 2016 and is headquartered in Mississauga, ON. | Health Technology |
POINT Biopharma, Inc. (United States)
POINT Biopharma, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Part of POINT Biopharma Global, Inc., POINT Biopharma, Inc. (United States) develops next-generation radioligand therapies for the treatment of cancer. The company is based in Indianapolis, IN. Joe McCann has been the CEO of the company since 2019. POINT Biopharma, Inc. (United States was acquired by Therapeutics Acquisition Corp. on June 30, 2021 for $578.95 million. | Commercial Services |
- Börse
- Insiders
- Neil Fleshner
- Erfahrung